FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response...
0.5                       
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Oliveira Steven Michael
2. Issuer Name and Ticker or Trading Symbol

Benitec Biopharma Inc. [ BNTC ]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                    __X__ 10% Owner
_____ Officer (give title below)    _____ Other (specify below)
(Last)          (First)          (Middle)

225 VIA PALACIO
3. Date of Earliest Transaction (MM/DD/YYYY)

4/28/2021
(Street)

PALM BEACH GARDENS, FL 33418
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0,0001 per share 4/28/2021  P  100000 A$5.4486 768123 I Through Nemean Asset Management, LLC 
Common Stock, par value $0,0001 per share 4/29/2021  P  22877 A$5.491 791000 I Through Nemean Asset Management, LLC 
Common Stock, par value $0,0001 per share 4/30/2021  P  120000 A$4.1824 911000 I Through Nemean Asset Management, LLC 
Common Stock, par value $0,0001 per share 5/3/2021  P  40500 A$4.2537 951500 I Through Nemean Asset Management, LLC 
Common Stock, par value $0,0001 per share 11/29/2021  P  37947 A$3.1804 989447 I Through Nemean Asset Management, LLC 
Common Stock, par value $0,0001 per share 12/9/2021  P  10553 A$3.0443 1000000 I Through Nemean Asset Management, LLC 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security3. Trans. Date3A. Deemed Execution Date, if any4. Trans. Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
6. Date Exercisable and Expiration Date7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
Oliveira Steven Michael
225 VIA PALACIO
PALM BEACH GARDENS, FL 33418

X


Signatures
/s/ Steven Michael Oliveira12/9/2021
**Signature of Reporting PersonDate

Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Benitec Biopharma Charts.
Benitec Biopharma (NASDAQ:BNTC)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Benitec Biopharma Charts.